Earnings Start To Grow Amid The Pandemic

Despite the third wave of COVID-19 infections and slow inoculations putting pressure on the recovery of Thailand-based and international patient volume, additional income from COVID-19-related services will enable BDMS’ revenue and earnings to start growing from this year onwards. Earnings growth next year will be well supported by the return of patient volume. Maintain BUY. Target price has been raised to Bt27.50.